
S2-E45.2 – Discussing Non-Invasive Testing and the Patient Experience with Wayne Eskridge.
Fatty Liver Foundation President Wayne Eskridge joins Louise Campbell and Roger Green to discuss why he is so enthusiastic about the FDA’s recent approval of the ELF test as a prognostic test for cirrhosis.